HHS Genetic Testing Advisory Committee To Include Device, CLIA Panel Reps
This article was originally published in The Gray Sheet
Executive Summary
HHS' planned Advisory Committee on Genetic Testing will include at least one active member of FDA's Medical Devices Advisory Committee and the Clinical Laboratory Improvement Advisory Committee, according to the group's charter.
You may also be interested in...
Genetic Testing Oversight Public Input Sought By HHS Advisory Panel
HHS' Advisory Committee on Genetic Testing will solicit public input at a Jan. 27 meeting to help determine an appropriate mechanism for the collection and analysis of data on the analytical validity, clinical validity and clinical utility of genetics tests, panel members agreed at their Oct. 26 meeting.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”